• Home
  • Category Archives: Influenza

Mutations create challenges for typing Influenza A virusesJan212016

From BCCDC: Today the Canadian Sentinel Practitioner Surveillance Network (SPSN) published a paper in Eurosurveillance, entitled “Mutations acquired during cell culture isolation may affect antigenic characterization of influenza A(H3N2) clade 3C.2a viruses”. The paper is available in full here (open access). We thought you would be interested in the findings, although like influenza itself, they… Read more »

Emerging Respiratory Virus Update: Avian flu, novel influenza, and MERS-CoVJan202016

From BCCDC: MAIN MESSAGES Human infections with avian influenza of various novel subtypes (H7N9, H5N6, H9N2, H5N1) have been reported from China recently, notably H7N9 for which a fourth wave of human cases is currently underway. As previously emphasized, avian influenza viruses, like humanized strains, show winter seasonality. Prior human infections with avian influenza H7N9… Read more »

New AMMI Antiviral Guidance for Influenza OutbreaksJan062016

In December 2015, the Association of Medical Microbiology and Infectious Disease Canada (AMMI) published an updated guidance document for the use of antivirals in the management of care facility influenza outbreaks for the 2015-16 season. Given the potential for low vaccine effectiveness of this season’s influenza vaccine, the AMMI guidance document states that, at the… Read more »

Emerging Respiratory Virus UpdateMar022015

From the BC Centre for Disease Control, February 27, 2015: There are a number of recent trends in the field of emerging respiratory viruses (ERV), including: 1.         Upswing in MERS-CoV reports from the Middle East, primarily Saudi Arabia, since December 2014. a.         In the context of the dramatic surge in MERS-CoV that occurred during the… Read more »